ArticleCase reports in urology2026
Pediatric Eosinophilic Cystitis: A Case Series From a Single Institution.
Article in Case reports in urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pediatric Eosinophilic Cystitis: A Case Series From a Single Institution.Case reports in urology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic cystitis (EC) is an inflammatory disease characterized by eosinophilic bladder infiltrate. It is primarily seen in adults with presenting symptoms of dysuria and gross hematuria, and diagnosis is confirmed with bladder biopsy. Possible etiologies include allergies, prior bladder trauma, or parasitic infections and management involves nonsteroidal anti-inflammatory drugs, antihistamines, corticosteroids, and occasionally immunologic agents. EC is rare and especially uncommon in the pediatric population. We present a case series of five pediatric patients diagnosed with EC over a 20-year review at a single institution, including how they presented and their management. This case series highlights the first pediatric case of EC requiring an immunologic agent for symptom control as well as several cases uniquely associated with schistosomiasis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.